Open Access

Genome‑wide DNA methylation analysis of uterosacral ligaments in women with pelvic organ prolapse

  • Authors:
    • Lifang Zhang
    • Ping Zheng
    • Aihong Duan
    • Yan Hao
    • Chang Lu
    • Dan Lu
  • View Affiliations

  • Published online on: November 13, 2018     https://doi.org/10.3892/mmr.2018.9656
  • Pages: 391-399
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pelvic organ prolapse (POP) is an increasingly serious health problem that impairs quality of life and is caused by multiple additive genetic and environmental factors. As the uterosacral ligaments (ULs) provide primary support for the pelvic organs, it was hypothesized that disruption of these ligaments (as a result of aberrant methylation) may lead to a loss of support and eventually contribute to POP. In the present study, whether there are any aberrant methylations in the ULs of patients with POP compared to those of controls was investigated. Genomic DNA was isolated from the ULs of five women with POP and four women without POP, as controls, undergoing hysterectomy for benign conditions. An Illumina Infinium Methylation EPICBeadChips Infinium Human Methylation 850 K bead array was used to investigate the total methylation in the ULs. There were 3,723 differentially methylated CpG sites (Δβ<0.14; P<0.05), including 3,576 hypermethylation and 147 hypomethylation sites in the ULs of patients with POP compared with the normal controls. There were more hypermethylated CpG sites, but a high ratio of hypomethylation between CpG islands and the N‑shelf; in the gene structure, there was more hypermethylation than hypomethylation in TSS1500 and the 5' untranslated region. Gene ontology analysis demonstrated that these differentially methylated genes were associated with ‘cell morphogenesis’, ‘extracellular matrix’, ‘cell junction’, ‘protein binding’ and ‘guanosine triphosphatase activity’. Several significant pathways were identified, including ‘focal adhesion’ and ‘extracellular matrix‑receptor interaction pathway’. This study provides evidence that there are differences in genome‑wide DNA methylation between ULs in menopausal women with and without POP, and that epigenetic mechanisms may partly contribute to POP pathogenesis.

Introduction

Pelvic organ prolapse (POP) is an increasingly serious health problem that impairs quality of life with a diverse clinical spectrum, including herniation of the uterus, bladder and/or rectum. This condition occurs with a high prevalence in postmenopausal women, with a lifetime risk of surgery for POP or urinary incontinence of 11% (1). This figure is expected to increase with the aging society.

Currently, despite the growing prevalence of POP, no consensus exists among researchers regarding its etiology and pathogenesis. There is no doubt, however, that it is a multifactorial disorder associated with a genetic predisposition. In addition, multiple additive genetic, environmental and lifestyle factors contribute to the pathogenesis of POP. Epidemiological studies have identified several risk factors, including age (2), race (3,4), parity (5,6) and obesity (5,7,8). However, these factors fail to explain the pathogenesis of POP in nulliparous women and to answer the question of why POP does not develop in all women exhibiting high-risk factors.

Recently several gene arrays for POP were revealed. Differential expression signatures were identified in 81 genes and specific extracellular matrix (ECM)-associated genes may participate in the pathology of POP, according to RNA-Seq data (9). Ak et al (10) reported, for the first time, that certain genes serve a role in the cell cycle, proliferation and embryonic development, along with cell adhesion processes during the development of POP, using gene chip microarrays, and a genome-wide association study (11) identified promising single nucleotide polymorphisms associated with POP. Recently published genome-wide linkage analysis (12) provided evidence for two additional loci in relation to symptomatic POP and whole-exome sequencing identified a novel gene, WNK1, that influences susceptibility to POP (13).

Generally, epigenetic regulation of gene transcription occurs by three main mechanisms: DNA methylation, histone modification and microRNA (miRNA) expression (14). DNA methylation, the most common epigenetic mechanism, leads to changes in gene expression without alteration of the DNA sequence. Aberrant (hyper or hypo-) methylation is believed to be greatly influenced by environmental risk factors. Klutke et al (15) first reported that methylation in the promoter region may suppress lysyl oxidase (LOX) gene expression in women with POP, but the DNA methylome of POP has never been characterized.

Since the uterosacral ligaments (ULs) provide primary support for the uterus and the upper vagina, it was hypothesized that the disruption of these ligaments may lead to a loss of support and eventually contribute to POP. In the present study, whether there is any aberrant methylation in the ULs of patients with POP compared to the controls was investigated.

Materials and methods

Tissue collection

Approval from the institutional review board was obtained from the Beijing Obstetrics and Gynecology Hospital Ethics Committee. Informed consent was obtained from all individual participants included in the study. A total of nine postmenopausal women, with five POP and four non-POP controls, undergoing hysterectomy for benign conditions were included, from January 2015 to June 2017. The clinicopathological characteristics of these patients are presented in Table I. In order to eliminate the intermixing factors between the experimental group and the control group, strict limits on inclusion and exclusion criteria were set for the uterine ligament samples. Exclusion criteria were as follows: Women with a history of connective tissue disorders, endometriosis, prior pelvic reconstructive surgery and cancer. Inclusion in the POP group required uterine prolapse beyond the hymen (stage 3 or stage 4) with/without cystocele and/or rectocele. Patient characteristics assessed included: Age, parity, body mass index (BMI), menopause, duration of menopausal period, history of hormone replacement therapy (HRT), smoking history and history of hypertension. The ULs were obtained during the procedures, providing ~1 g of tissue per sample.

Table I.

Clinical characteristics.

Table I.

Clinical characteristics.

CharacteristicsPOP (n=5)CON (n=4)P-value
Age (years)
  Range   60.60±5.23 (55–66)   61.25±6.65 (53–68)NS
BMI (kg/m2)24.84±2.1726.80±5.74NS
Pregnancy (n)
  Range   3.6±1.14 (2–5)2.75±0.05 (2–3)NS
Parity (n)2.00±0.001.75±0.50NS
  Patients (n) without vaginal delivery00
  Patients (n) one vaginal delivery01
  Patients (n) two vaginal deliveries53
Menopause (n)54
During of menopausal period (years)
  Range10.20±4.82 (5–16)11.00±7.79 (4–20)NS
Smoking (n)00
Suffering from hypertension (n)12

[i] NS, not significant; BMI, body mass index; POP, pelvic organ prolapse; CON, control.

DNA extraction

DNA was isolated using an OMEGA TISSUE DNA kit (Omega Bio-Tek, Inc., Norcross, GA, USA), according to the manufacturer's protocol. DNA was quantified by spectrophotometry (NanoDrop; Thermo Fisher Scientific, Inc., Wilmington, DE, USA). Genomic DNA (500 ng) was treated with bisulfate using an EZ DNA Methylation Gold kit (Zymo Research Corps., Irvine, CA, USA), according to the manufacturer's protocol.

Microarray experiments

Microarray experiment correction for multiple testing was done in order to separate the most significant differences from the background noise. Prior to microarray experiments, clustering test was done between the two groups. POP and control subjects were separated (Data not shown). The methylation of DNA was assayed on an Illumina Infinium Methylation EPICBeadChip (Illumina, Inc., San Diego, CA, USA) using the Illumina HD methylation assay kit from Shanghai Biotechnology Corporation (Shanghai, China). Each of these arrays contained 853,307 probes, covered CpG islands, RefSeq genes, ENCODE open chromatin, ENCODE transcription factor binding sites and FANTOM5 enhancers. Bisulfite-converted DNA was analyzed on an EPICBeadChip following the manufacturer's protocol. GenomeStudio methylation module V.1.9.0 (Illumina, Inc.) was used to extract the image intensities.

Statistical analysis and microarray data analysis

Clinical characteristics were analyzed using SPSS software version 17.0 (SPSS, Inc., Chicago, IL, USA). Statistical significance for the t-test was determined to be at the level of P<0.05. Values are expressed as the mean and standard deviation.

The CpG probe signal intensities were normalized using Subset-Quantile Within Array Normalization in the minfi packages from R Bioconductor (16) for background correction and subtraction. Methylation values for individual CpG sites were obtained as β-values, calculated as the ratio of the methylated signal intensity to the sum of the methylated and unmethylated signals following background subtraction. The β-values were reported as a DNA methylation score ranging from 0 (non-methylated) to 1 (completely methylated). Initially, probes located on the sex chromosome were excluded. Differentially methylated CpGs were selected using an algorithm in IMA Bioconductor. In the present study, the mean-difference β-value (Δβ) between the two sample groups for each CpG site was assessed. Specifically, a probe was considered to be differentially methylated if the absolute Δβ was higher than 0.14 and the statistical test was significant (P<0.05 was considered to indicate a statistically significant difference). The interaction network was generated using the Search Tool for the Retrieval of Interacting Genes (STRING) database (string-db.org) to analyze genes from the experiments and text mining.

Results

Clinical characteristics of all participants

A total of 9 subjects were recorded, including five patients with POP and 4 controls. ULs were obtained from a total of 9 hysterectomies. The overall grade of prolapse was 3–4 and the degree of uterine prolapse was grade 3–4 beyond the hymen. Clinical characteristics of all participants included in the study are presented in Table I.

Differential methylation and expression profiling in POP

DNA methylation analysis identified 3,723 differentially methylated CpG sites; 0.4% of the total sites in POP ULs were detected, compared to the controls (Fig. 1A). Surprisingly, the hypermethylated CpG site accounted for ~96.1% (3,576), which was markedly higher than the number of hypomethylated ones (147 CpG sites, 3.9%, Fig. 1B). Notably, in methylated CpG content and neighborhood context (Shore: 0–2 k distance around the island; Shelf: 2 to 4 k distance around the island), there was a difference between hypermethylation and hypomethylation; hypermethylated CpG site percentages were 4.4, 3.2, 6.8, 2.9, 5.9 and 76.9% in Island, N-Shelf, N-Shore, S-Shore, S-Shelf and Open Sea, respectively. However, hypomethylated CpG site percentages were 8.2, 6.1, 5.4, 4.8, 6.1 and 69.4% in Island, N-Shelf, N-Shore, S-Shore, S-Shelf and Open Sea, respectively. In particular, more hypomethylated CpG sites were detected in Island and N-Shelf (Fig. 1C and D). Hypermethylated and hypomethylated CpG sites are presented in Fig. 1C and D in chromosomal locations. Finally, probes from the X and Y chromosomes were excluded due to the partial homology of the X and Y chromosomes, and the fact that the 9 samples were females. As for gene structure, there was significant difference (TSS1500, TSS200, 5′UTR, 1st Exon, Body, 3′UTR and others) between hypermethylation and hypomethylation; in particular, there was greater hypermethylation residing in TSS1500 and 5′UTR compared with hypomethylation. Detailed differences in gene structure are presented in Fig. 1C and D.

Heat maps of differential methylation are presented in Fig. 2. Total methylation of POP samples was markedly different from that of the controls; however, in the POP group, samples POP4 and POP5 were more similar to each other, and were slightly different from the other three POP samples.

GO analysis of the differentially methylated genes in POP

To begin defining the functional significance of the extensive changes in DNA methylation in POP, GO analysis was used. According to the functions of the differential genes, the top 20 in each category were listed, respectively, in molecular function, biological process and cellular component (Fig. 3). These differentially methylated genes were widely associated with cell morphogenesis, the extracellular matrix, cell junctions, protein binding and guanosine triphosphatase (GTPase) activity.

KEGG analysis of the differentially methylated genes in POP

To further investigate key pathways associated with these distinct genes, the interaction network of the significant pathways associated with POP was built according to the KEGG database. The analysis in the present study demonstrated that these differentially methylated genes were widely involved in various cellular pathways. There were a total of 206 pathways associated with POP and the top 20 included ‘ErbB signaling pathway’, ‘pathways in cancer’, ‘focal adhesion’ and ‘ECM-receptor interaction’ (presented in Fig. 4). Notably, ‘focal adhesion’ and ‘ECM-receptor interaction’ were enriched in the top 3 and top 4 of differentially methylated profiling in the top 20 enriched pathways. The two pathways of the differentially methylated genes are listed in Table II.

Table II.

KEGG analysis of distinct methylated genes in pathways. KEGG analysis of distinct hepermethylated genes and hypomethylated genes in focal adhesion and ECM-receptor interaction pathways.

Table II.

KEGG analysis of distinct methylated genes in pathways. KEGG analysis of distinct hepermethylated genes and hypomethylated genes in focal adhesion and ECM-receptor interaction pathways.

Pathway IDDescriptionP-valueHypermethylated GenesHypomethylated Genes
hsa04510Focal adhesion 3.38×10−05COL5A1 LAMB1 ITGA9 PDK1 FYN VWF AKT3 COL1A2 VEGFC MAPK9 ZYX BCAR1 CRK PARVB PIK3R1 PIK3CB THBS2 FN1 ITGAV COL11A2 PRKCA LAMB3 SOS1 CAPN2 LAMA2 DOCK1 RASGRF1 TNR COL6A3 PTK2 MYLK3 COL4A1 ITGB5 COL5A2 FIGFITGA8
hsa04512ECM-receptor interaction 1.18×10−04COL5A1 LAMB1 SDC2 ITGA9 VWF COL1A2 THBS2 FN1 ITGAV COL11A2 LAMB3 LAMA2 TNR COL6A3 COL4A1 ITGB5 CD44 COL5A2ITGA8

[i] KEGG, Kyoto encyclopedia of genes and genomes; ECM, extracellular matrix.

Network analysis in POP

The STRING was used to provide information regarding predicted and experimental interactions of proteins. Differentially expressed genes were demonstrated to be enriched via methylation profiling and literature mining in the focal adhesion and ECM-receptor interaction pathways (Fig. 5); furthermore, the nodes with higher degrees of interaction were considered as hub nodes. The top 5 nodes were integrin (IGTB1; degree=43), fibronectin (FN1; degree=39), protein tyrosine kinase (PTK2; degree=38), cluster of differentiation (CD)44 (degree=37) and integrin (IGTA1; degree=37).

Discussion

Emerging evidence indicates that epigenetic mechanisms may partly contribute to the pathogenesis of POP (15). However, until now there had been no reports on genome-wide DNA methylation profiling in POP, except the LOX methylation. Klutke et al (15) measured promoter methylation in the LOX gene in women with POP and found a total of 66 methylated CpG sites in the POP group and only one methylated CpG site in the non-prolapse control group. In the present study, it was reported that there were 3,723 differentially methylated CpG sites, 0.4% of the total sites in POP ULs compared with the controls in menopausal women.

In general, increased DNA methylation means higher levels of gene expression (17). Over the past decades, a number of studies have revealed that a considerable percentage of CpG site methylation varies with age (18), giving rise to genome-wide hypomethylation with site-specific incidences of hypermethylation. Notably, tumors have a unique methylation pattern with high levels of hypomethylation (19). In the present study, the five menopausal women with POP and the four without POP demonstrated a unique methylation pattern with low levels of hypomethylation, which may partly be associated with aging. The age range of the nine subjects was between 53 and 68 years old and therefore all were menopausal women. As for the sample limitations, age-associated variations in methylation should be further investigated in the future.

DNA methylation is a key epigenetic process involved in the regulation of gene expression. There is no doubt, however, that POP is a multifactorial disorder with a genetic predisposition, determined by interactions between additive genetic, environmental and lifestyle factors. As presented in the heat map, hypermethylation and hypomethylation were obviously different between POPs and controls, demonstrating their contribution to the pathogenesis of POP. Notably, with respect to the methylation within the POP group, POP4 and POP5 were more similar to each other and slightly different from the other three. Analyzing the clinical characteristics, it was demonstrated that the duration of menopause in the two cases was ~15 years, but it was five, six and ten years in the other three. These two POP cases were older than the other three also; there were no differences in parity or BMI. Therefore, age and duration of menopause may be highly associated with methylation.

For DNA methylation profiling, gene ontology analysis was used to separately assess molecular function, biological processes and cellular components. In biological processes, the enriched terms were ‘anatomical structure morphogenesis’, ‘anatomical structure development’, ‘cell morphogenesis’, ‘locomotion involved in differentiation’, ‘cellular component movement’ and ‘locomotion’, which was likely due to the pelvic organs moving from their normal anatomical position, accounting for prolapse. In the cellular component category, the terms were ‘proteinaceous extracellular matrix’, ‘cell junction’, ‘cell periphery’, ‘adherens junction’, ‘basement membrane’, ‘cell-cell junction’ and ‘collagen’, indicating that POP may be associated with the ECM. In the molecular function category, the terms were ‘cytoskeletal protein binding’, ‘actin binding’, ‘calmodulin binding’, ‘GTPase regulator activity’, ‘calcium channel activity’, ‘calcium-release channel activity’ and ‘protein binding’. Similarly, previous evidence has demonstrated that several families, including collagen (2022), LOX (15,2325) and fibulin (25), have important roles in the synthetic metabolism and pathogenesis of POP; however, in the catabolism of the pathogenesis of POP, matrix metalloproteinase (2630) and tissue inhibitors of metalloproteinase serve vital roles (27,30). In the regulation of anabolic and catabolic processes, the homeobox gene family is key (31,32). Notably, in the present study, it was demonstrated that specific key members of the families mentioned above were detected to be DNA methylated in the molecular function, biological process and cellular component categories.

KEGG analysis of expression profiling suggested that the ‘focal adhesion’ and ‘ECM-receptor interaction’ pathways may potentially serve direct or indirect roles in POP; however, to date, no studies have linked them to POP. Notably, the two pathways contained only one hypomethylated gene, ITGA8; however, ITGAV was hypermethylated in the two pathways. A hypomethylated gene tends to indicate a high expression level, with hypermethylation meaning lower expression, in accordance with Kufaishi's studies (33,34) in vaginal cells derived from premenopausal women with and without severe POP. Li et al (35) demonstrated that mechanical strain could activate the phosphoionositide 3 kinase/protein kinase B signaling pathway in POP. Chen (36) reported that smooth muscle cells could activate the TGFER2/ALK5/mothers against decapentaplegic homolog 2 (Smad)2 and Smad3 signaling pathways, which may indicate a potential approach for the management of POP. In these two pathways certain genes, which were differentially methylated in POP were demonstrated.

Integrins are transmembrane receptors facilitating cell-ECM adhesion and activating signal transduction pathways. Not only do they bind cells to the ECM, they also regulate the cell cycle, organize the intracellular cytoskeleton and translocate novel receptors to the cell membrane (37). Several types of integrins exist and one cell may have multiple different types on its surface. Integrins interact with the ECM to generate large molecular complexes by focal adhesions. The study of Rhee et al (38) revealed that POP is associated with alterations in the sphingosine-1-phosphate/Rho-kinase signaling pathway, which could be reduced by a Rho-kinase inhibitor. Apart from ITGAV, there were two other genes, which were hypermethylated, ITGA9 and ITGB5, which require further investigation. In the network, ITGAV (degree=32), ITGA9 (degree=27) and ITGA8 (degree=25) were highly connected. This suggested that the integrin family may include hub genes in POP. Fibronectin is the main part of the ECM and while rarely mentioned with regard to POP, may be another important hub gene.

In the present study, there were certain limitations. All the ULs were from menopausal women and premenopausal women were not included. The number in each group was relatively small. Since microarray experiments use large numbers of variables (genes) in a small number of samples, standard power analysis determination according to standard hypothesis testing cannot be applied (39). Pavlidis et al reported (39) that 8–15 subjects in each group is sufficient to obtain near-maximal levels of power in array studies. Gene expression and functional tests were not performed. Although this issue was not the subject of this study, the products of these genes and their functions should be further investigated in future studies.

In conclusion, the present study demonstrated and elaborated upon the differences in genome-wide DNA methylation between POP ULs and controls. Epigenetic mechanisms may partly contribute to the pathogenesis of POP.

Acknowledgements

Not applicable.

Funding

The present study was supported by Beijing Obstetrics & Gynecology Hospital affiliated Capital Medical University Funds (Project no. fcyy201407).

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Authors' contributions

LZ analyzed and interpreted the data, wrote the paper. DL helped editing the paper. LZ, PZ, AD, YH, CL and DL collected the tissues.

Ethics approval and consent to participate

The institutional review board was obtained from the Beijing Obstetrics and Gynecology Hospital Ethics Committee. The study was approved in written by Ethics Committee. Informed consent was obtained from all individual participants included in the study.

Patient consent for publication

Informed consent was obtained from all individual participants included in the study.

Competing interests

The authors declare they have no competing interests.

Glossary

Abbreviations

Abbreviations:

POP

Pelvic organ prolapse

UL

uterosacral ligaments

ECM

extracellular matrix

LOX

lysyl oxidase gene

References

1 

DeLancey JO: The hidden epidemic of pelvic floor dysfunction: Achievable goals for improved prevention and treatment. Am J Obstet Gynecol. 192:1488–1495. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J and Brody DJ: Pelvic Floor Disorders Network: Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 300:1311–1316. 2008. View Article : Google Scholar : PubMed/NCBI

3 

Whitcomb EL, Rortveit G, Brown JS, Creasman JM, Thom DH, Van Den Eeden SK and Subak LL: Racial differences in pelvic organ prolapse. Obstet Gynecol. 114:1271–1277. 2009. View Article : Google Scholar : PubMed/NCBI

4 

Rortveit G, Brown JS, Thom DH, Van Den Eeden SK, Creasman JM and Subak LL: Symptomatic pelvic organ prolapse: Prevalence and risk factors in a population-based, racially diverse cohort. Obstet Gynecol. 109:1396–1403. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V and McTiernan A: Pelvic organ prolapse in the Women's Health Initiative: Gravity and gravidity. Am J Obstet Gynecol. 186:1160–1166. 2002. View Article : Google Scholar : PubMed/NCBI

6 

Glazener C, Elders A, Macarthur C, Lancashire RJ, Herbison P, Hagen S, Dean N, Bain C, Toozs-Hobson P, Richardson K, et al: Childbirth and prolapse: Long-term associations with the symptoms and objective measurement of pelvic organ prolapse. BJOG. 120:161–168. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Bradley CS, Zimmerman MB, Qi Y and Nygaard IE: Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol. 109:848–854. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Kudish BI, Iglesia CB, Sokol RJ, Cochrane B, Richter HE, Larson J, Hendrix SL and Howard BV: Effect of weight change on natural history of pelvic organ prolapse. Obstet Gynecol. 113:81–88. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Xie R, Xu Y, Fan S and Song Y: Identification of differentially expressed genes in pelvic organ prolapse by RNA-Seq. Med Sci Monit. 22:4218–4225. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Ak H, Zeybek B, Atay S, Askar N, Akdemir A and Aydin HH: Microarray gene expression analysis of uterosacral ligaments in uterine prolapse. Clin Biochem. 49:1238–1242. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Allen-Brady K, Cannon-Albright L, Farnham JM, Teerlink C, Vierhout ME, van Kempen LC, Kluivers KB and Norton PA: Identification of six loci associated with pelvic organ prolapse using genome-wide association analysis. Obstet Gynecol. 118:1345–1353. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Allen-Brady K, Cannon-Albright LA, Farnham JM and Norton PA: Evidence for pelvic organ prolapse predisposition genes on chromosomes 10 and 17. Am J Obstet Gynecol. 212:771.e1–e7. 2015. View Article : Google Scholar

13 

Rao S, Lang J, Zhu L and Chen J: Exome sequencing identifies a novel gene, WNK1, for susceptibility to pelvic organ prolapse (POP). PLoS One. 10:e01194822015. View Article : Google Scholar : PubMed/NCBI

14 

Sui X, Zhu J, Zhou J, Wang X, Li D, Han W, Fang Y and Pan H: Epigenetic modifications as regulatory elements of autophagy in cancer. Cancer Lett. 360:106–113. 2015. View Article : Google Scholar : PubMed/NCBI

15 

Klutke J, Stanczyk FZ, Ji Q, Campeau JD and Klutke CG: Suppression of lysyl oxidase gene expression by methylation in pelvic organ prolapse. Int Urogynecol J. 21:869–872. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD and Irizarry RA: Minfi: A flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 30:1363–1369. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Bird AP and Wolffe AP: Methylation-induced repression-belts, braces, and chromatin. Cell. 99:451–454. 1999. View Article : Google Scholar : PubMed/NCBI

18 

Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Padbury JF, Bueno R, et al: Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 5:e10006022009. View Article : Google Scholar : PubMed/NCBI

19 

Rang FJ and Boonstra J: Causes and consequences of age-related changes in DNA methylation: A Role for ROS? Biology (Basel). 3:403–425. 2014.PubMed/NCBI

20 

Borazjani A, Kow N, Harris S, Ridgeway B and Damaser MS: Transcriptional regulation of connective tissue metabolism genes in women with pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 23:44–52. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Sun MJ, Cheng YS, Sun R, Cheng WL and Liu CS: Changes in mitochondrial DNA copy number and extracellular matrix (ECM) proteins in the uterosacral ligaments of premenopausal women with pelvic organ prolapse. Taiwan J Obstet Gynecol. 55:9–15. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Connell KA, Guess MK, Chen H, Andikyan V, Bercik R and Taylor HS: HOXA11 is critical for development and maintenance of uterosacral ligaments and deficient in pelvic prolapse. J Clin Invest. 118:1050–1055. 2008.PubMed/NCBI

23 

Alarab M, Bortolini MA, Drutz H, Lye S and Shynlova O: LOX family enzymes expression in vaginal tissue of premenopausal women with severe pelvic organ prolapse. Int Urogynecol J. 21:1397–1404. 2010. View Article : Google Scholar : PubMed/NCBI

24 

Kobak W, Lu J, Hardart A, Zhang C, Stanczyk FZ and Felix JC: Expression of lysyl oxidase and transforming growth factor beta2 in women with severe pelvic organ prolapse. J Reprod Med. 50:827–831. 2005.PubMed/NCBI

25 

Klutke J, Ji Q, Campeau J, Starcher B, Felix JC, Stanczyk FZ and Klutke C: Decreased endopelvic fascia elastin content in uterine prolapse. Acta Obstet Gynecol Scand. 87:111–115. 2008. View Article : Google Scholar : PubMed/NCBI

26 

Wang X, Li Y, Chen J, Guo X, Guan H and Li C: Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse. Mol Med Rep. 10:2004–2008. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Alarab M, Kufaishi H, Lye S, Drutz H and Shynlova O: Expression of extracellular matrix-remodeling proteins is altered in vaginal tissue of premenopausal women with severe pelvic organ prolapse. Reprod Sci. 21:704–715. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Usta A, Guzin K, Kanter M, Ozgul M and Usta CS: Expression of matrix metalloproteinase-1 in round ligament and uterosacral ligament tissue from women with pelvic organ prolapse. J Mol Histol. 45:275–281. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Yilmaz N, Ozaksit G, Terzi YK, Yilmaz S, Budak B, Aksakal O and Sahin FI: HOXA11 and MMP2 gene expression in uterosacral ligaments of women with pelvic organ prolapse. J Turk Ger Gynecol Assoc. 15:104–108. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Liang CC, Huang HY and Chang SD: Gene expression and immunoreactivity of elastolytic enzymes in the uterosacral ligaments from women with uterine prolapse. Reprod Sci. 19:354–359. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Ma Y, Guess M, Datar A, Hennessey A, Cardenas I, Johnson J and Connell KA: Knockdown of Hoxa11 in vivo in the uterosacral ligament and uterus of mice results in altered collagen and matrix metalloproteinase activity. Biol Reprod. 86:1002012. View Article : Google Scholar : PubMed/NCBI

32 

Connell KA, Guess MK, Chen HW, Lynch T, Bercik R and Taylor HS: HOXA11 promotes fibroblast proliferation and regulates p53 in uterosacral ligaments. Reprod Sci. 16:694–700. 2009. View Article : Google Scholar : PubMed/NCBI

33 

Kufaishi H, Alarab M, Drutz H, Lye S and Shynlova O: Comparative characterization of vaginal cells derived from premenopausal women with and without severe pelvic organ prolapse. Reprod Sci. 23:931–943. 2016. View Article : Google Scholar : PubMed/NCBI

34 

Kufaishi H, Alarab M, Drutz H, Lye S and Shynlova O: Static mechanical loading influences the expression of extracellular matrix and cell adhesion proteins in vaginal cells derived from premenopausal women with severe pelvic organ prolapse. Reprod Sci. 23:978–992. 2016. View Article : Google Scholar : PubMed/NCBI

35 

Li BS, Guo WJ, Hong L, Liu YD, Liu C, Hong SS, Wu DB and Min J: Role of mechanical strain-activated PI3K/Akt signaling pathway in pelvic organ prolapse. Mol Med Rep. 14:243–253. 2016. View Article : Google Scholar : PubMed/NCBI

36 

Chen X, Kong X, Liu D, Gao P, Zhang Y, Li P and Liu M: In vitro differentiation of endometrial regenerative cells into smooth muscle cells: Alpha potential approach for the management of pelvic organ prolapse. Int J Mol Med. 38:95–104. 2016. View Article : Google Scholar : PubMed/NCBI

37 

Giancotti FG and Ruoslahti E: Integrin signaling. Science. 285:1028–1032. 1999. View Article : Google Scholar : PubMed/NCBI

38 

Rhee SH, Zhang P, Hunter K, Mama ST, Caraballo R, Holzberg AS, Seftel RH, Seftel AD, Echols KT and DiSanto ME: Pelvic organ prolapse is associated with alteration of sphingosine-1-phosphate/Rho-kinase signalling pathway in human vaginal wall. J Obstet Gynaecol. 35:726–732. 2015. View Article : Google Scholar : PubMed/NCBI

39 

Pavlidis P, Li Q and Noble WS: The effect of replication on gene expression microarray experiments. Bioinformatics. 19:1620–1627. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

January-2019
Volume 19 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang L, Zheng P, Duan A, Hao Y, Lu C and Lu D: Genome‑wide DNA methylation analysis of uterosacral ligaments in women with pelvic organ prolapse. Mol Med Rep 19: 391-399, 2019
APA
Zhang, L., Zheng, P., Duan, A., Hao, Y., Lu, C., & Lu, D. (2019). Genome‑wide DNA methylation analysis of uterosacral ligaments in women with pelvic organ prolapse. Molecular Medicine Reports, 19, 391-399. https://doi.org/10.3892/mmr.2018.9656
MLA
Zhang, L., Zheng, P., Duan, A., Hao, Y., Lu, C., Lu, D."Genome‑wide DNA methylation analysis of uterosacral ligaments in women with pelvic organ prolapse". Molecular Medicine Reports 19.1 (2019): 391-399.
Chicago
Zhang, L., Zheng, P., Duan, A., Hao, Y., Lu, C., Lu, D."Genome‑wide DNA methylation analysis of uterosacral ligaments in women with pelvic organ prolapse". Molecular Medicine Reports 19, no. 1 (2019): 391-399. https://doi.org/10.3892/mmr.2018.9656